FCBG414QD3C50 Vidiny (USD) [237pcs Stock]
- 1 pcs$236.19158
- 2 pcs$235.01650
- Ampahany:
- FCBG414QD3C50
- Manufacturer:
- Finisar Corporation
- Famaritana antsipirihany:
- CABLE OPT 4X14G FULL-DUPLEX QSFP. Fiber Optic Cable Assemblies 4x14G, full-duplex, QSFP cable ends, electrical limiting interface, RoHS, multimode, 0/70 C operation, 850nm VCSEL array, PIN array, round riser/LSZH cable, 50m length, Ge
- Manufacturer's standard lead time:
- Ao amin'ny staoky
- Fiainana an-trano:
- Iray taona
- Chip From:
- Hong Kong
- RoHS:
- Fomba fandoavam-bola:
-
- Fomba fandefasana:
- Fianakaviana:
- KEY Components Co., LTD dia Elektronika Mpanome Elektronika izay manolotra sokajy vokatra ao anatin'izany: Fivoriana manokana tariby manokana, Barrel - Tariby Audio, Fivondronana tariby efatra sosona, Cables modular, Tondraka - tariby herinaratra, Jiro, tariby an-tariby ary tariby fanitarana, Tariby afon-tsolika (IEEE 1394) and Eo anelanelan'ny Cables Adapter ...
- Ny tombony azo amin'ny fifaninanana:
- We specialize in Finisar Corporation FCBG414QD3C50 electronic components. FCBG414QD3C50 can be shipped within 24 hours after order. If you have any demands for FCBG414QD3C50, Please submit a Request for Quotation here or send us an email: rfq@key-components.com
FCBG414QD3C50 Toetran'ny vokatra
Ampahany :
FCBG414QD3C50
Manufacturer :
Finisar Corporation
Description :
CABLE OPT 4X14G FULL-DUPLEX QSFP
Series :
-
Ampahany :
Active
Mpamatsy tariby :
-
Isan'ny laharana :
-
Type mpamatsy :
-
Gender :
-
Karazana fifadian-kanina :
-
Toetoetra :
-
Karazana tariby :
-
Fampiasana :
-
Length :
-
Color :
-
fiarovana :
-
Vaovao farany
Mety ho liana koa ianao
-
N282-03M-28-BK
Tripp Lite
CABLE QSFP M-M 3M. Ethernet Cables / Networking Cables 3M QSFP28 to QSFP28 100Gbe Passive DAC Copper InfiniBand Cable
-
N282-02M-28-BK
Tripp Lite
CABLE QSFP M-M 2M. Ethernet Cables / Networking Cables 2M QSFP28 to QSFP28 100Gbe Passive DAC Copper InfiniBand Cable
-
-
-
-
Faritra mafana
- 10124109-2090LF
- FCBN414QB1CX0
- FCBR425QB1C30
- FCBN425QE1C10
- AFBR-7QER01Z
- QSSFP-P01M0-1
- 6A11-A0121-080.0-0
- 0745261003
- FCBG110SD1C01B
- FCF8-20-01-L-13.90-S
- ICD040GVP163D-01
- 2083110-5
- 0745570001
- 1110401705
- 1002971215
- 2083109-5
- 10127771-2030LF
- 10117984-4060HLF
- 6A44-B0421-014.0-0
- 6A22-A0421-001.0-0
- FCBND12CD1CX0
- PCIEO-4G3-010.0-11
- 6A44-B0441-017.0-0
- 10120612-2090LF
- PCIEC-098-0300-EC-EM-P
- 6A22-D0421-017.0-0
- ICD150GVP341A-50
- 6A22-A0441-050.0-0
- ICD040GVP163D-20
- 10127773-2090LF
- 0745063001
- FCBP110LD1L10
- 1110404805
- 6A22-A0441-027.0-0
- 10127771-2040LF
- ICD120GVP2410-20
- FCBP110LD1L03S
- 0745951060
- 10111728-15S300HLF
- 10115006-7SS146HLF